-
MVdeltaC Receives FDA Orphan Drug Designation in Pleural Mesothelioma
12 Jun 2025 22:10 GMT
… human tumor cell lines, including mesothelioma, lung adenocarcinoma, hepatocarcinoma, and bladder … confirmed following local administration in mesothelioma patient-derived xenograft models and … .1 criteria and a 72% survival rate, which increased to 100% when …
-
Guest Editorial – The national mesothelioma registry: A path to better care for Linn County’s veterans
05 Jun 2025 18:14 GMT
… limited. Furthermore, as mesothelioma first manifests with non- … stage diagnosis and a survival rate of under a year, … implementation of a National Mesothelioma Registry. In practice, … implementation of the National Mesothelioma Registry. By raising awareness …
-
BNT327/PM8002 Plus Chemo Is Active in Unresectable Pleural and Peritoneal Mesothelioma
04 Jun 2025 19:14 GMT
… = 31), the confirmed overall response rate (cORR) was 51.6% (95% … chemotherapy improved overall survival (OS) and progression-free survival (PFS) outcomes vs … . In the overall, pleural mesothelioma, and peritoneal mesothelioma populations, the respective 15 …
-
Tumor Treating Fields Boost Pancreatic Cancer Survival
01 Jun 2025 22:54 GMT
… including glioblastomas, metastatic pleural mesothelioma, and metastatic non-small … .039), and the 1-year survival rate was similarly better (68.1% … 1-year pain-free survival rate 54.1% vs 45. … adenocarcinoma and a predictor of survival. Thus, by mitigating …
-
Enhancing mesothelioma diagnosis and treatment for New York veterans through a national registry
27 May 2025 15:09 GMT
… concerns in addressing mesothelioma in veterans is the high rate of misdiagnosis … . Recent statistics posted by Mesothelioma Guide indicate … reduce the chances of patients’ survival.
One primary reason for these …
-
Merck Announces Phase 3 KEYNOTE-B96 Trial Met Primary Endpoint of Progression-Free Survival (PFS) in Patients With Platinum-Resistant Recurrent Ovarian Cancer Whose Tumors Expressed PD-L1 and in All Comers
15 May 2025 11:10 GMT
… regimen has demonstrated an overall survival benefit in ovarian cancer,” said … or IIIA NSCLC.
Malignant Pleural Mesothelioma
KEYTRUDA, in combination with pemetrexed … factors, including interest rate and currency exchange rate fluctuations; the impact …
-
HITOCH After Surgery Appears Safe, May Improve Survival in Mesothelioma
06 May 2025 19:07 GMT
… The 30-day mortality rate was 0% vs 3 … with malignant pleural mesothelioma after cytoreductive surgical procedures … survival among low-risk patients with malignant pleural mesothelioma … patients with malignant pleural mesothelioma intolerable to extrapleural …
-
KEYTRUDA® (pembrolizumab) as Perioperative Treatment With Standard of Care (SOC) Adjuvant Therapy Significantly Improved Event-Free Survival Compared to SOC Alone in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
27 Apr 2025 16:10 GMT
… major pathological response (mPR) rate, a key secondary endpoint, … trend toward improvement in overall survival (OS), another key … at a ≥10% higher rate in pediatric patients when … advanced or metastatic malignant pleural mesothelioma (MPM).
Classical Hodgkin …
-
Health Canada Approves Pembrolizumab/Chemotherapy for Unresectable, Advanced or Metastatic Pleural Mesothelioma
22 Apr 2025 18:35 GMT
… overall survival (OS), progression-free survival (PFS), and overall response rate (ORR … patients with advanced malignant pleural mesothelioma. ClinicalTrials.gov. Updated December … advanced or metastatic malignant pleural mesothelioma. FDA. September 17, 2024 …
-
Mesothelioma Treatment Approved by Health Canada
22 Apr 2025 17:55 GMT
… advanced or metastatic malignant pleural mesothelioma (MPM). The approval is based … in overall survival (OS), progression-free survival (PFS) and overall response rate (ORR … advanced or metastatic malignant pleural mesothelioma, a condition that often has …
About
© 1995-2025